Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Cipla elevates Umang Vohra as COO; promoter scion to head M&A, VC unit
Mumbai-based drugmaker Cipla Ltd on Thursday expanded the role of promoter group scion Samina Vaziralli and appointed a new global ......
Healthcare
Narayana Health shares shoot up in market debut
Narayana Hrudayalaya Pvt Ltd, the country's second-largest hospital chain by the number of operational beds, made a strong stock market ......
Healthcare
Outlook 2016: Five things to look out for in healthcare
Coming on the back of what was a record year for private investments and equally busy year with bold overseas ......
Healthcare
Zydus Cadila buys select animal health brands of Zoetis
Drugmaker Cadila Healthcare Ltd, which runs under the brand Zydus Cadila, said on Tuesday it has acquired some animal health ......
Healthcare
Syngene names AstraZeneca's Jonathan Hunt CEO
Syngene International Ltd, the research and development unit of biopharmaceutical firm Biocon Ltd, said on Monday it has appointed Jonathan ......
Healthcare
Thyrocare files draft IPO papers
Thyrocare Technologies Ltd, India's largest thyroid testing company, has filed draft papers with market regulator Securities and Exchange Board of ......
Healthcare
Cadila slapped with US FDA warning on two facilities
Shares of drugmaker Cadila Healthcare Ltd plunged as much as 15 per cent in intra-day trade on Thursday after the ......
Healthcare
Recap 2015: PE investment in healthcare hits record high
Private investments in the healthcare sector rose to an estimated $1.6 billion this year, surpassing the previous peak clocked two ......
Healthcare
Thyrocare to file draft IPO papers next week
India's largest thyroid testing company Thyrocare Technologies Ltd will file the draft red herring prospectus (DRHP) with market regulator Securities ......
Healthcare
Recap 2015: Healthcare firms go public; drugmakers make overseas push
It was another year of steady growth for firms in the healthcare sector as drugmakers made bold bets abroad and ......









